Trutino Biosciences
PrivateLast Round
Convertible Debt
Jun 14, 2022
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Trutino Biosciences operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Convertible Debt round in June 2022.
Trutino Biosciences is a biopharmaceutical company that develops next-generation cytokine therapies to treat immuno-oncology and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trutino Biosciences Comparables
Compare Trutino Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Asher Biotherapeutics | 87% | |
| Synthekine | 83% | |
| Bright Peak Therapeutics | 81% |
For institutional investors. Book with your work email.
Trutino Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Jun 14, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Trutino Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boehringer Ingelheim | Convertible Debt |
| Creative Destruction Lab | Seed |
| Partners Investment | Seed |
| Johnson & Johnson Innovation - JLABS | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 6763% from 57 to 3.9K.
- Jan 19, 2026
Monthly visitors grew 47% MoM, reaching 1K.
For institutional investors. Book with your work email.
Trutino Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Trutino Biosciences's valuation, stock price, and market status.
Is Trutino Biosciences a public or private company?
Trutino Biosciences is a private company.
What is the current stock price of Trutino Biosciences?
Trutino Biosciences is a private company, so its shares have no public market price. Caplight tracks Trutino Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Trutino Biosciences worth (valuation)?
Valuation information for Trutino Biosciences is not publicly available.
Can I buy Trutino Biosciences stock?
Trutino Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Trutino Biosciences's last funding round?
Trutino Biosciences's most recent funding round was Convertible Debt on June 14, 2022.
Who are the main investors in Trutino Biosciences?
Key investors in Trutino Biosciences include Boehringer Ingelheim.
Will Trutino Biosciences IPO soon?
No public IPO plans have been announced for Trutino Biosciences.
How can I track Trutino Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Trutino Biosciences's shares on secondary markets.